Skip to Main Content

School of Public Health: Anis Emilia

Researchers / חוקרים

 Last updated September 2023 - School of Public Health

List of Publications


Balash Y, Kahana E, Korczyn AD, Wolker M, Nabal H, Anis E, et al. Is There Horizontal Transmission of Creutzfeldt-Jakob Disease? Neuroepidemiology [Internet]. 2023;57(3):156–61. Available from:


Anis E, Preis SA, Cedar N, Tal Y, Hershkowitz I, Hershko AY. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel. Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2022;10(11):2969–76. Available from:


Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al. Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel. Circulation [Internet]. 2022;146(10):802–4. Available from:


Stein M, Grossman Z, Brosh-Nissimov T, Gottesman BS, Shahar A, Wechsler E, et al. How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12–15 years before regulatory approval. Acta Paediatrica, International Journal of Paediatrics [Internet]. 2022;111(4):834–41. Available from:


Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. New England Journal of Medicine [Internet]. 2022;386(10):998–9. Available from:


Haas EJ, McLaughlin JM, Khan F, Angulo FJ, Anis E, Lipsitch M, et al. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. The Lancet Infectious Diseases [Internet]. 2022;22(3):357–66. Available from:


Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine. Vaccines [Internet]. 2022;10(2). Available from:


Gorelik Y, Anis E, Edelstein M. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. The Lancet Regional Health - Europe [Internet]. 2022;12. Available from:


Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. New England Journal of Medicine [Internet]. 2021;385(23):2140–9. Available from:


Singer SR, Angulo FJ, Swerdlow DL, McLaughlin JM, Hazan I, Ginish N, et al. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine [Internet]. 2021;42. Available from:


Anis E, Haas EJ, Indenbaum V, Singer SR, Warshavsky B, Rishpon S, et al. A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19. Journal of Infection [Internet]. 2021;83(6):678–85. Available from:


Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015–2016. Vaccine [Internet]. 2021;39(48):7101–7. Available from:


Perepliotchikov Y, Ziv-Baran T, Hindiyeh M, Manor Y, Sofer D, Moran-Gilad J, et al. Inferring numbers of wild poliovirus excretors using quantitative environmental surveillance. Vaccines [Internet]. 2021;9(8). Available from:


Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, et al. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. European Journal of Epidemiology [Internet]. 2021;36(7):727–34. Available from:


Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet [Internet]. 2021;397(10287):1819–29. Available from:


Gozlan Y, Bar-Or I, Volnowitz H, Asulin E, Rich R, Anis E, et al. Lessons from intensified surveillance of viral hepatitis a, Israel, 2017 and 2018. Eurosurveillance [Internet]. 2021;26(6). Available from:


Langsam D, Anis E, Haas EJ, Gosinov R, Yechezkel M, Grotto I, et al. Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis. Vaccine [Internet]. 2020;38(12):2700–6. Available from:


Tur-Sinai A, Gur-Arie R, Davidovitch N, Kopel E, Glazer Y, Anis E, et al. Vaccination uptake and income inequalities within a mass vaccination campaign. Israel Journal of Health Policy Research [Internet]. 2019;8(1). Available from:


Bercovich S, Anis E, Kassem E, Rubinstein U, Ephros M, Cohen D, et al. Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry. Vaccine [Internet]. 2019;37(21):2791–6. Available from:


Salama M, Amitai Z, Lustig Y, Mor Z, Weiberger M, Chowers M, et al. Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases. Travel Medicine and Infectious Disease [Internet]. 2019;28:41–5. Available from:


Lustig Y, Gosinov R, Zuckerman N, Glazer Y, Orshan L, Sofer D, et al. Epidemiologic and phylogenetic analysis of the 2018 west Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I. Eurosurveillance [Internet]. 2019;24(1). Available from:


Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Reemergence of human brucellosis in Israel. Israel Medical Association Journal [Internet]. 2019;21(1):10–2. Available from:


Elran B, Yaari S, Glazer Y, Honovich M, Grotto I, Anis E. Parents’ perceptions of childhood immunization in Israel: Information and concerns. Vaccine [Internet]. 2018;36(52):8062–8. Available from:


Adamker G, Holzer T, Karakis I, Amitay M, Anis E, Singer SR, et al. Prediction of Shigellosis outcomes in Israel using machine learning classifiers. Epidemiology and Infection [Internet]. 2018;146(11):1445–51. Available from:


Anis E, Moerman L, Ginsberg G, Karakis I, Slater PE, Warshavsky B, et al. Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel? Journal of Public Health Policy [Internet]. 2018;39(3):304–17. Available from:


Rosenberg Danziger C, Anis E, Gordon ES, Grotto I, Danon YL. Reintroducing OPV in Israel on the journey to global polio eradication – Estimation at a low rate of contraindicated population. Vaccine [Internet]. 2018;36(26):3717–20. Available from:


Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Association between human brucellosis and adverse pregnancy outcome: a cross-sectional population-based study. European Journal of Clinical Microbiology and Infectious Diseases [Internet]. 2018;37(5):883–8. Available from:


Dadon Y, Haas EJ, Kaliner E, Anis E, Singer SR, Atiya-Nasagi Y, et al. Outbreak of human leptospirosis linked to contaminated water bodies in Northern Israel, June to August 2018. Eurosurveillance [Internet]. 2018;23(38). Available from:


Muhsen K, Anis E, Rubinstein U, Kassem E, Goren S, Shulman LM, et al. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011–2015: a case–control study. Clinical Microbiology and Infection [Internet]. 2018;24(1):53–9. Available from:


Lustig Y, Kaufman Z, Mendelson E, Orshan L, Anis E, Glazer Y, et al. Spatial distribution of West Nile virus in humans and mosquitoes in Israel, 2000–2014. International Journal of Infectious Diseases [Internet]. 2017;64:20–6. Available from:


Indenbaum V, Hübschen JM, Stein-Zamir C, Mendelson E, Sofer D, Hindiyeh M, et al. Ongoing mumps outbreak in Israel, January to August 2017. Eurosurveillance [Internet]. 2017;22(35). Available from:


Gozlan Y, Bar-Or I, Rakovsky A, Savion M, Amitai Z, Sheffer R, et al. Ongoing hepatitis a among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 – June 2017. Eurosurveillance [Internet]. 2017;22(29). Available from:


Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Israel Journal of Health Policy Research [Internet]. 2017;6(1). Available from:


Tasher D, Kopel E, Anis E, Grossman Z, Somekh E. Causality assessment of serious neurologic adverse events following the bOPV national vaccination campaign in Israel. Israel Medical Association Journal [Internet]. 2016;18(10):590–3. Available from:


Glatman-Freedman A, Kaufman Z, Kopel E, Bassal R, Taran D, Valinsky L, et al. Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting. Journal of Infection [Internet]. 2016;73(2):99–106. Available from:


Tasher D, Rahav G, Levine H, Sofer D, Linder N, Anis E, et al. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine [Internet]. 2016;34(3):299–301. Available from:


Brosh-Nissimov T, Poles L, Kassirer M, Singer R, Kaliner E, Shriki DD, et al. Preparing for imported ebola cases in israel, 2014 to 2015. Eurosurveillance [Internet]. 2015;20(44). Available from:


Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, et al. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Eurosurveillance [Internet]. 2015;20(42). Available from:


Kaliner E, Kopel E, Anis E, Mendelson E, Moran-Gilad J, Shulman LM, et al. The Israeli public health response to wild poliovirus importation. The Lancet Infectious Diseases [Internet]. 2015;15(10):1236–42. Available from:


Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. Journal of Infectious Diseases [Internet]. 2015;211(11):1800–12. Available from:


Levine H, Kopel E, Anis E, Givon-Lavi N, Dagan R. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012. Eurosurveillance [Internet]. 2015;20(7). Available from:


Kopel E, Grotto I, Grossman T, Haklai Z, Marva E, Anis E. Long-term predictors of recurrent laboratory-confirmed giardiasis: A 10-year national surveillance study. Journal of the Pediatric Infectious Diseases Society [Internet]. 2014;3(4):343–6. Available from:


Shulman LM, Mendelson E, Anis E, Bassal R, Gdalevich M, Hindiyeh M, et al. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013. Journal of Infectious Diseases [Internet]. 2014;210:S304–14. Available from:


Elinav H, Hershko-Klement A, Valinsky L, Jaffe J, Wiseman A, Shimon H, et al. Pregnancy-associated listeriosis: Clinical characteristics and geospatial analysis of a 10-year period in Israel. Clinical Infectious Diseases [Internet]. 2014;59(7):953–61. Available from:


Gandacu D, Glazer Y, Anis E, Karakis I, Warshavsky B, Slater P, et al. Resurgence of cutaneous leishmaniasis in Israel, 2001-2012. Emerging Infectious Diseases [Internet]. 2014;20(10):1605–11. Available from:


Anis E, Grotto I, Mendelson E, Bin H, Orshan L, Gandacu D, et al. West Nile fever in Israel: The reemergence of an endemic disease. Journal of Infection [Internet]. 2014;68(2):170–5. Available from:


Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, et al. Molecular epidemiology of Legionnaires’ disease in Israel. Clinical Microbiology and Infection [Internet]. 2014;20(7):690–6. Available from:


Anis E, Grotto I, Moerman L, Kaliner E, Warshavsky B, Slater PE, et al. Rubella in Israel after the MMR vaccine: Elimination or containment? Journal of Public Health Policy [Internet]. 2013;34(2):288–301. Available from:


Avidor B, Turner D, Mor Z, Chalom S, Riesenberg K, Shahar E, et al. Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy. PLoS ONE [Internet]. 2013;8(3). Available from:


Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y. Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis. Israel Journal of Health Policy Research [Internet]. 2013;2(1). Available from:


Anis E, Kopel E, Singer SR, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into israel, 2013. Eurosurveillance [Internet]. 2013;18(38). Available from:


Levy Y, Anis E, Kaliner E, Grotto I, Danon YL. Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel. Vaccine [Internet]. 2012;30(47):6632–5. Available from:


Moran-Gilad J, Lazarovitch T, Mentasti M, Harrison T, Weinberger M, Mordish Y, et al. Huhumidifier-associated paediatric legionnaires’ disease, Israel, February 2012. Eurosurveillance [Internet]. 2012;17(41). Available from:


Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel’s highly vaccinated society: Are two doses enough? Epidemiology and Infection [Internet]. 2012;140(3):439–46. Available from:


Engelhard D, Bromberg M, Averbuch D, Tenenbaum A, Goldmann D, Kunin M, et al. Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal infl uenza among children, Israel. Emerging Infectious Diseases [Internet]. 2011;17(9):1740–3. Available from:


Anis E, Leventhal A, Grotto I, Gandacu D, Warshavsky B, Shimshony A, et al. Recent trends in human brucellosis in Israel. Israel Medical Association Journal [Internet]. 2011;13(6):359–62. Available from:


Levy I, Mor Z, Anis E, Maayan S, Leshem E, Pollack S, et al. Men who have sex with men, risk behavior, and HIV infection: Integrative analysis of clinical, epidemiological, and laboratory databases. Clinical Infectious Diseases [Internet]. 2011;52(11):1363–70. Available from:


Muhsen K, Shohat T, Aboudy Y, Mendelson E, Algor N, Anis E, et al. Sero-prevalence of mumps antibodies in subpopulations subsequently affected: By a large scale mumps epidemic in Israel. Vaccine [Internet]. 2011;29(22):3878–82. Available from:


Anis E, Leventhal A, Slater PE, Arbeli Y, Sivan Y, Berlovitz Y, et al. A cluster of deaths following influenza vaccination, Israel, 2006. Journal of Public Health Policy [Internet]. 2010;31(3):318–23. Available from:


Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B, et al. Measles in a highly vaccinated society: The 2007-08 outbreak in Israel. Journal of Infection [Internet]. 2009;59(4):252–8. Available from:


Anis E, Leventhal A, Slater PE, Shinar E, Yahalom V, Smetana Z, et al. Smallpox revaccination of 21 000 first responders in Israel: lessons learned. International Journal of Infectious Diseases [Internet]. 2009;13(3):403–9. Available from:


Balicer RD, Anis E, Goldmann D, Dahan D, Singer R, Grotto I. Influenza A/H1N1 in Israel–clinical and epidemiological characteristics. Harefuah [Internet]. 2009;148(11):738–42, 795. Available from:


Pezzoli L, Elson R, Little CL, Yip H, Fisher I, Yishai R, et al. Packed with Salmonella - Investigation of an international outbreak of Salmonella Senftenberg infection linked to contamination of prepacked Basil in 2007. Foodborne Pathogens and Disease [Internet]. 2008;5(5):661–8. Available from:


Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. Journal of Hepatology [Internet]. 2007;47(4):514–20. Available from:


Moerman L, Leventhal A, Slater PE, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. Israel Medical Association Journal [Internet]. 2006;8(5):308–11. Available from:


Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA [Internet]. 2005;294(2):202–10. Available from:


Ben-Ami R, Siegman-Igra Y, Anis E, Brook GJ, Pitlik S, Dan M, et al. Malaria in travelers returning from short organized tours to holiday resorts in Mombassa, Kenya. Israel Medical Association Journal [Internet]. 2005;7(6):364–7. Available from:


Sidi G, Davidovitch N, Balicer RD, Anis E, Grotto I, Schwartz E. Tickborne relapsing fever in Israel. Emerging Infectious Diseases [Internet]. 2005;11(11):1784–6. Available from:


Anis E, Pener H, Goldmann D, Leventhal A. The reemergence of malaria in Israel? Harefuah [Internet]. 2004;143(11):815–9. Available from:


Ben-Simon GJ, Peiss M, Anis E, Nakra T, Luski A, Spierer A. Spectacle use and reduced unaided vision in third grade students: A comparative study in different educational settings. Clinical and Experimental Optometry [Internet]. 2004;87(3):175–9. Available from:


Green MS, Anis E, Gandacu D, Grotto I. The fall and rise of gonorrhoea incidence in Israel: An international phenomenon? Sexually Transmitted Infections [Internet]. 2003;79(2):116–8. Available from:


Slater PE, Anis E, Leventhal A. Communicable Disease Control: An introductory course for MPH students. Public Health Reviews [Internet]. 2002;30(1–4):327–38. Available from:


Slater PE, Anis E, Leventhal A. Preparation for an outbreak of smallpox in Israel. Israel Medical Association Journal [Internet]. 2002;4(7):507–12. Available from:


Green MS, Aharonowitz G, Shohat T, Levine R, Anis E, Slater PE. The changing epidemiology of viral hepatitis A in Israel. Israel Medical Association Journal [Internet]. 2001;3(5):347–51. Available from:


Slater PE, Leventhal A, Anis E. The elimination of smallpox from Israel. Israel Medical Association Journal [Internet]. 2001;3(1):71–2. Available from:


Anis E, Leventhal A, Elkana Y, Wilamowski A, Pener H. Cutaneous leishmaniasis in Israel in the era of changing environment. Public Health Reviews [Internet]. 2001;29(1):37–47. Available from:


Anis E, Leventhal A, Roitman M, Slater PE. Introduction of routine hepatitis A immunization in Israel–the first in the world. Harefuah [Internet]. 2000;138(3):177–80, 272. Available from:


Aharonowitz G, Koton S, Segal S, Anis E, Green MS. Epidemiological characteristics of spotted fever in Israel over 26 years. Clinical Infectious Diseases [Internet]. 1999;29(5):1321–2. Available from:


Slater PE, Anis E, Leventhal A. Measles control in Israel: A decade of the two-dose policy. Public Health Reviews [Internet]. 1999;27(1–3):235–41. Available from:


Slater PE, Anis E, Leventhal A. The control of mumps in Israel. European Journal of Epidemiology [Internet]. 1999;15(8):765–7. Available from:


Dagan R, Fraser D, Roitman M, Slater P, Anis E, Ashkenazi S, et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. Vaccine [Internet]. 1999;17(2):134–41. Available from:


Ostroi P, Anis E, Green MS. Shigellosis in Israel - Update 1995. Public Health Reviews [Internet]. 1996;24(3–4):213–25. Available from:


Slater PE, Roitman M, Leventhal A, Anis E. Control of rubella in Israel: Progress and challenge. Public Health Reviews [Internet]. 1996;24(2):183–92. Available from:


Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. The Lancet [Internet]. 1995;346(8976):660–2. Available from:


Slater PE, Roitman M, Anis E. Failure of mass chemoprophylaxis to control hyperendemic meningococcal disease. Public health reviews [Internet]. 1995;23(4):367–9. Available from: